Trends of drug treatment for neurogenic bladder in children
10.3760/cma.j.issn.2095-428X.2017.23.022
- VernacularTitle:小儿神经源性膀胱药物治疗及现状
- Author:
Chaoxu WANG
1
;
Weiping ZHANG
Author Information
1. 100045,首都医科大学附属北京儿童医院泌尿外科
- Keywords:
Neurogenic bladder;
Child;
Drug therapy
- From:
Chinese Journal of Applied Clinical Pediatrics
2017;32(23):1833-1835
- CountryChina
- Language:Chinese
-
Abstract:
The neurogenic urinary bladder in children is defined as a dysfunctional bladder associated with a known neurological injury which can cause voiding dysfunction and serious damage to the upper urinary tract. There are many principles of treatment available for patients with a neurogenic bladder,and drug therapy is one of the major treat-ments. The main goals for drug therapy are lowering storage pressures,preventing detrusor overactivity and lowering the residual volume and treating or preventing urinary tract infections. As more and more new drugs are put into clinical trials,the quality of life of patients with neurogenic bladder is improved and complications are reduced. However,due to the special nature of groups of children,the clinical application of drugs is relatively cautious,the effectiveness of treat-ment is not clear. This article reviews the data on pharmaceutical agents used in the treatment of neurogenic bladder in children in order to improve the medical quality and prognosis.
